BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29843004)

  • 1. An ultra-sensitive Abbott ARCHITECT
    Lou S; Taylor R; Pearce S; Kuhns M; Leary T
    J Clin Virol; 2018 Aug; 105():18-25. PubMed ID: 29843004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An improved Abbott ARCHITECT assay for the detection of hepatitis B virus surface antigen (HBsAg).
    Lou SC; Pearce SK; Lukaszewska TX; Taylor RE; Williams GT; Leary TP
    J Clin Virol; 2011 May; 51(1):59-63. PubMed ID: 21367654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
    Martin LA; Stramer SL; Kuhns MC; Schlauder GG
    Transfusion; 2012 Oct; 52(10):2201-8. PubMed ID: 22321072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors.
    Kuhns MC; McNamara AL; Holzmayer V; Cloherty GA
    Virol J; 2019 Apr; 16(1):43. PubMed ID: 30943997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a novel chemiluminescent microplate enzyme immunoassay for hepatitis B surface antigen detection.
    Yang L; Song LW; Fang LL; Wu Y; Ge SX; Li H; Yuan Q; Zhang J; Xia NS
    J Virol Methods; 2016 Feb; 228():55-9. PubMed ID: 26615806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.
    Kuhns MC; Busch MP
    Mol Diagn Ther; 2006; 10(2):77-91. PubMed ID: 16669606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-center evaluation of the hepatitis B surface antigen (HBsAg) assay and HbsAg confirmatory assay for the family of Access immunoassay systems.
    Lunel-Fabiani F; Duburcq X; Levayer T; Descamps F; Maniez-Montreuil M; Pivert A; Ducancelle A; Pouzet A; Marant L; Clèment A; Duhamel D; Leirens Y; Margotteau F; Falcou-Briatte R; Heinen C; Bouniort F; Taskar S; Artus A; Woodrum D; Flecheux O
    Clin Lab; 2010; 56(7-8):281-90. PubMed ID: 20857892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved detection of early acute, late acute, and occult Hepatitis B infections by an increased sensitivity HBsAg assay.
    Kuhns MC; Holzmayer V; McNamara AL; Sickinger E; Schultess J; Cloherty GA
    J Clin Virol; 2019 Sep; 118():41-45. PubMed ID: 31442662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay.
    Tsoi WC; Lelie N; Lin CK
    Transfusion; 2013 Oct; 53(10 Pt 2):2477-88. PubMed ID: 23521050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections.
    Vermeulen M; Coleman C; Mitchel J; Reddy R; van Drimmelen H; Ficket T; Lelie N
    Transfusion; 2013 Oct; 53(10 Pt 2):2459-66. PubMed ID: 23621791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Dynamics of Hepatitis B Virus (HBV)-DNA and Surface Antigen (HBsAg) in Ramp-Up Phase of Viremia: Implications for Performance Evaluation of Blood Screening Assays.
    van Drimmelen H; Lelie N
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantial variation in the hepatitis B surface antigen (HBsAg) in hepatitis B virus (HBV)-positive patients from South Africa: Reliable detection of HBV by the Elecsys HBsAg II assay.
    Gencay M; Vermeulen M; Neofytos D; Westergaard G; Pabinger S; Kriegner A; Seffner A; Gohl P; Huebner K; Nauck M; Kaminski WE
    J Clin Virol; 2018 Apr; 101():38-43. PubMed ID: 29414186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of in vivo hepatitis B virus surface antigen mutations-A comparison of four routine screening assays.
    Gencay M; Seffner A; Pabinger S; Gautier J; Gohl P; Weizenegger M; Neofytos D; Batrla R; Woeste A; Kim HS; Westergaard G; Reinsch C; Brill E; Thuy PTT; Hoang BH; Sonderup M; Spearman CW; Brancaccio G; Fasano M; Gaeta GB; Santantonio T; Kaminski WE
    J Viral Hepat; 2018 Oct; 25(10):1132-1138. PubMed ID: 29660206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characteristics of HBV infection among blood donors tested HBsAg reactive in a single ELISA test in southern China.
    Ye X; Li T; Li R; Liu H; Zhao J; Zeng J
    BMC Infect Dis; 2021 Jan; 21(1):83. PubMed ID: 33468062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing.
    Lelie N; Bruhn R; Busch M; Vermeulen M; Tsoi WC; Kleinman S;
    Transfusion; 2017 Jan; 57(1):24-35. PubMed ID: 27673757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRISM hepatitis B surface antigen detection of hepatits B virus minipool nucleic acid testing yield samples.
    Linauts S; Saldanha J; Strong DM
    Transfusion; 2008 Jul; 48(7):1376-82. PubMed ID: 18422847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage.
    Yoshikawa A; Gotanda Y; Minegishi K; Taira R; Hino S; Tadokoro K; Ohnuma H; Miyakawa K; Tachibana K; Mizoguchi H;
    Transfusion; 2007 Jul; 47(7):1162-71. PubMed ID: 17581150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel hepatitis B virus surface antigen immunoassay as sensitive as hepatitis B virus nucleic acid testing in detecting early infection.
    Matsubara N; Kusano O; Sugamata Y; Itoh T; Mizuii M; Tanaka J; Yoshizawa H
    Transfusion; 2009 Mar; 49(3):585-95. PubMed ID: 19192255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reliability of HBV core antibody in serological screening for hepatitis B virus.
    Ba Alawi F; Robertson PW; LePage AK; Jayamaha J; Baleriola C; Rawlinson WD
    Pathology; 2013 Aug; 45(5):501-5. PubMed ID: 23842045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.